Showing results (181-190 of 531) with videos related to

Sort By:
Pageof 54
The American Journal of Cardiology|May 27, 2006
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy)James C Blankenship, Tom Haldis, Frederick Feit, et al.
The American Journal of Cardiology|December 26, 2015
Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials)Vivian G Ng, Andreas Baumbach, Liliana Grinfeld, et al.
The American Journal of Cardiology|October 7, 2004
ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy)Fernando A Cura, Marco Roffi, Narcis Pasca, et al.
Human Pathology|January 18, 2011
Toluene optic neurotoxicity: magnetic resonance imaging and pathologic featuresShelly R Gupta, Cheryl Ann Palmer, Joel K Curé, et al.
Circulation|August 11, 2004
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary interventionSorin J Brener, David J Moliterno, A Michael Lincoff, et al.
European Journal of Preventive Cardiology|March 14, 2019
Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysisHaris Riaz, Safi U Khan, Hammad Rahman, et al.
Circulation. Cardiovascular Interventions|February 10, 2012
Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trialChristopher W Good, Steven R Steinhubl, Danielle M Brennan, et al.
European Heart Journal|November 1, 1995
Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptorE M Ohman, R A Harrington, A M Lincoff, et al.
Neurology|May 1, 1994
Mitochondrial DNA mutations in an outbreak of optic neuropathy in CubaM Hirano, J M Cleary, A M Stewart, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat modelZhongmin Zhou, Marc S Penn, Farhad Forudi, et al.
Pageof 54